A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years

Phase 4 Completed 1275 enrolled University of Oxford National Institute for Health Research, United Kingdom · collab University of Dundee · collab

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this trial is to determine whether iodide supplementation of neonates born under 31 weeks gestation improves neurodevelopment measured at two years of age.

Timeline

Start: 2010-03
Primary completion: 2015-04
Completion: 2015-05

Publications

Background Williams F, Hume R, Ogston S, Brocklehurst P, Morgan K, Juszczak E; I2S2 team. A summary of the iodine supplementation study protocol (I2S2): a UK multicentre randomised controlled trial in preterm infants. Neonatology. 2014;105(4):282-9. doi: 10.1159/000358247. Epub 2014 Feb 27.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sodium Iodide	Unknown	30 ug/kg	—

A Randomised Controlled Trial of Iodide Supplementation in Preterm Infants Follow-up at 2 Years

Summary

Timeline

Publications

Drugs

Indications